The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID-19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
More than 38.54 crore (38,54,01,150) vaccine doses have been provided to States/UTs so far, through all sources.
Of this, the total consumption including wastages is 36,80,68,124 doses (as per data available at 8 AM today).
More than 1.73 Cr (1,73,33,026) balance and unutilized COVID Vaccine doses are still available with the States/UTs and private hospitals to be administered.
37.21 Cr. Vaccine Doses administered so far under Nationwide Vaccination Drive
India reports 42,766 new cases in last 24 hours
India's Active Caseload currently at 4,55,033
Active cases constitute 1.48% of total cases
2,99,33,538 Total Recoveries across the country so far
45,254 patients recovered during last 24 hours
Recovery Rate increases to 97.20%
Weekly Positivity Rate remains below 5%, currently at 2.34%
Daily positivity rate at 2.19%, less than 3% for 19 consecutive days
Testing capacity substantially ramped up – 42.90 cr tests total conducted
India’s cumulative vaccination coverage crossed 37crore yesterday. A total of 37,21,96,268 vaccine doses have been administered through 48,04,423sessions, as per the provisional report till 7 am today. 30,55,802 vaccine doses were administered in the last 24 hours.
These include:
The new phase of universalization of COVID-19 vaccination commenced from 21st June, 2021. The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.
India has reported 42,766 daily new cases in the last 24 hours.
Less than 50,000 Daily New Cases have been reported since thirteen continuous days. This is a result of sustained and collaborative efforts by the Centre and the States/UTs.
India’s Active Caseload today stands at 4,55,033 and active cases are now only 1.48% of the country's total Positive Cases.
Out of the people infected since the beginning of the pandemic, 2,99,33,538 people have already recovered from COVID-19 and 45,254 patients have recovered in the last 24 hours. This constitutes an overall recovery rate of 97.20%, which is showing a sustained increasing trend.
With substantially ramped up testing capacity across the country, a total of 19,55,225tests were conducted in the last 24 hours in the country. Cumulatively, India has conducted over 42.90 crore (42,90,41,970) tests so far.
While on one side testing capacity has been enhanced across the country, a continued decline in weekly case positivity is noticed. Weekly Positivity Rate is currently at 2.34% while the Daily Positivity rate stands at 2.19% today. Daily Positivity rate has remained less than 3% for 19 consecutive days, and has remained below 5% for 33 consecutive days now.
In a landmark achievement, India’s cumulative vaccination coverage surpassed 36 crores yesterday. A total of 36,13,23,548 vaccine doses have been administered through 47,07,778 sessions, as per the provisional report till 7 am today. 36,05,998 vaccine doses were administered in the last 24 hours.
These include:
The new phase of universalization of COVID19 vaccination commenced from 21st June, 2021. The Union Government is committed to accelerating the pace and expanding the scope of COVID19 vaccination throughout the country.
India has reported 43,733 daily new cases in the last 24 hours.
Less than 50,000 Daily New Cases have been reported since ten continuous days. This is a result of sustained and collaborative efforts by the Centre and the States/UTs.
India has also been witnessing a continuous fall in the active caseload. The country’s Active Caseload today stands at 4,59,920.
A net decline of 4,437 is witnessed in the last 24 hours and active cases are now only 1.50% of the country's total Positive Cases.
As more people are getting recovered from COVID-19 infection, India’s Daily Recoveries continue to outnumber the Daily New Cases for 55 consecutive days now. 47,240 recoveries were registered in the last 24 hours.
More than 3,000 (3,507) recoveries were reported during the last 24 hours as compared to the daily new cases.
Out of the people infected since the beginning of the pandemic, 2,97,99,534 people have already recovered from COVID-19 and 47,240 patients have recovered in the last 24 hours. This constitutes an overall recovery rate of 97.18%, which is showing a sustained increasing trend.
With substantially ramped up testing capacity across the country, a total of 19,07,216 tests were conducted in the last 24 hours in the country. Cumulatively, India has conducted over 42.33 crore (42,33,32,097) tests so far.
While on one side testing capacity has been enhanced across the country, a continued decline in weekly case positivity is noticed. Weekly Positivity Rate is currently at 2.39% while the Daily Positivity rate stands at 2.29% today. Daily Positivity rate has remained less than 3% for 16 consecutive days now, and has remained below 5% less for a month.
36.13 Cr. Vaccine Doses administered so far under Nationwide Vaccination Drive
India reports 43,733 new cases in last 24 hours
India's Active Caseload declines to 4,59,920
Active cases constitute 1.5% of total cases
2,97,99,534 Total Recoveries across the country so far
47,240 patients recovered during last 24 hours
Daily recoveries continue to outnumber the Daily New Cases for the 55th consecutive day
Recovery Rate increases to 97.18%
Weekly Positivity Rate remains below 5%, currently at 2.39%
Daily positivity rate at 2.29%, less than 3% for 16 consecutive days
Testing capacity substantially ramped up – 42.33 cr tests total conducted
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
More than 37.43 crore (37,43,25,560) vaccine doses have been provided to States/UTs so far, through all sources and a further 48,65,110 doses are in the pipeline.
Of this, the total consumption including wastages is 35,75,98,947 doses (as per data available at 8 AM today).
More than 1.67 Cr (1,67,26,613) balance and unutilized COVID Vaccine doses are still available with the States/UTs and private hospitals to be administered.
The Union Government has been leading the fight against the global pandemic with a ‘Whole of Government’ and ‘Whole of Society’ approach. As an ongoing effort to strengthen efforts of various State/UT Governments for COVID management, the Central Government has been deputing Central teams from time to time to visit various States/UTs. These teams interact with the State/UT authorities and get a first-hand understanding of the challenges and issues being faced by them so as to strengthen their ongoing activities and remove bottlenecks, if any.
The Centre has today deputed multi-disciplinary teams to Kerala, Arunachal Pradesh, Tripura, Odisha, Chhattisgarh and Manipur in view of the increased number of COVID-19 cases being reported by these States. The team to Manipur will be led by Dr. L Swasticharan, Add. DDG & Director EMR; team to Arunachal Pradesh will be led by Dr. Sanjay Sadhukhan, Professor AIIH&PH; for Tripura Dr. R.N. Sinha Dir Professor, AIIH&PH; for Kerala Dr. Ruchi Jain, Public Health Specialist Gr. II, RoHFW; for Odisha Dr. A Dan, Public Health Specialist AIIH&PH and for Chhattisgarh Dr. Dibakar Sahu, Assistant Professor, AIIMS Raipur. Teams will be supporting them in their efforts for targeted COVID response and management, and effectively tackling the pandemic.
The two-member high level team to these states consists of a clinician and a public health expert. The teams will visit the States immediately and monitor the overall implementation of COVID-19 management, especially in testing, including surveillance and containment operations; COVID Appropriate Behaviour and its enforcement; availability of hospital beds, sufficient logistics including ambulances, ventilators, medical oxygen etc., and COVID-19 Vaccination progress. The teams will monitor the situation and also suggest remedial actions.
The Central teams will assess the situation and suggest remedial actions on public health activities to the respective state governments. Copy of the report will also be provided to the Union Health Ministry.
Based on recommendations from National Technical Advisory Group on Immunization (NTAGI), the Union Ministry of Health and family Welfare (MoHFW) today approved the vaccination of pregnant women against COVID-19. The decision empowers pregnant women to make an informed choice on taking the COVID vaccination. The decision has been communicated to all the States/ UTs to implement it under the ongoing National COVID Vaccination Program.
India’s National COVID Vaccination program incorporates recommendations of the foremost experts in the field of immunization, public health, disease control and information technology. Based on scientific and epidemiological evidence, the programme gives priority to strengthening the country’s healthcare system by protecting the professionals, health and frontline workers, manning it, as well as protecting the most vulnerable population groups. Till date, all groups except pregnant women were eligible for COVID-19 vaccination. Now, it is expanded to even pregnant women in the world’s largest Immunization drive.
Studies have shown that COVID-19 infection during pregnancy may result in rapid deterioration of health of pregnant women and they are at an increased risk of severe diseases and it might affect fetus too. The matter has been examined by domain knowledge experts based on the evidence that indicate that pregnant women are at an increased risk for severe illness from COVID-19 compared to non-pregnant women in case they get infected. Further, pregnant women with COVID-19 infection are at an increased risk for preterm birth and other adverse pregnancy outcomes including higher chances of neonatal morbidity. Additionally, the experts have also highlighted pre-existing co-morbidities, advanced maternal age, and high body mass Index as factors for severe COVID-19 in pregnancy.
The National Technical Advisory Group on Immunization (NTAGI) has recommended vaccination for pregnant women. The National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) too has unanimously recommended it. Further, a national level Consultation on COVID-19 vaccination for pregnant women was also convened by the Union Ministry of Health and Family Welfare to build consensus on COVID Vaccination of pregnant women. The consultation unanimously welcomed the recommendation of NTAGI to vaccinate pregnant women. The consultation included professional bodies like FOGSI, representatives of State Governments, CSOs, NGOs, Development Partner agencies, technical experts etc.
The Ministry of Health and Family Welfare has accepted these recommendations and prepared an Operational Guideline for vaccination of pregnant women, Counselling kit for Medical Officers and FLWs, and IEC material for general public to equip the States/ UTs to carry out the vaccination of pregnant women. Pregnant woman, who opts for vaccination, can be vaccinated with COVID-19 vaccines available in the country any time during their pregnancy at the nearest Government or Private COVID-19 Vaccination Center (CVC) after registration on CoWIN or by walk-in registration at the nearest CVC. The procedures and modalities of COVID-19 vaccination like registration, generation of certificates after vaccination etc. will remain the same as it is for any beneficiaries above 18 years of age under the National COVID Vaccination Program.
Union Minister for Chemicals and Fertilizers Shri D.V Sadananda Gowda announced that an additional 1,14,000 vials of Liposomal Amphotericin-B, used in the treatment for Mucormycosis have been allocated to all the States/UTs and Central Institutions today.
The Minister also informed that so far, over 11 Lakh vials have been allocated across the country, maintaining adequate availability to patients of Mucormycosis.
Dr Harsh Vardhan, Union Minister for Health and Family Welfare addressed an audienceof eminent doctors, professors of medical science and stalwarts of medical fraternity specializing in Cervical Pathology and Colposcopy through video-conference yesternight at the inaugural session of the 17th World Congress for Cervical Pathology and Colposcopy.
The event organised by Indian Society of Colposcopy and Cervical Pathology was inaugurated by Hon’ble Vice President Shri Venkaiah Naidu.
Dr. Harsh Vardhan congratulated the Indian Society of Colposcopy and Cervical Pathology for pioneering training in colposcopy and treatment of precancerous lesions of the cervix and for bringing the prestigious World Congress for the first time to Asia. The theme of the World congress “Eliminating Cervical Cancer: Call for Action” is aligned to the WHO call for Elimination of Cervical Cancer by 2030, he stated.
Speaking on the topic of cervical cancer, the Union Health Minister said, “It is the fourth most common cancer in women. It affects over half a million women across the world each year, and kills a quarter of a million. It is tragic that one woman dies of cervical cancer every two minutes, making it one of the greatest threats to women’s health. The sad part is that our women are suffering and dying despite the fact that when diagnosed cervical cancer is one of the most successfully treatable forms of cancer, as long as it is detected early and managed effectively. Cancers diagnosed in late stages can also be controlled with appropriate treatment and palliative care. With a comprehensive approach to prevent, screen and treat, cervical cancer can be eliminated as a public health problem within a generation.” The Minister also informed that so far, over 11 Lakh vials have been allocated across the country, maintaining adequate availability to patients of Mucormycosis.
Dr. Harsh Vardhan also highlighted the crucial role undertaken by India to stop cervical cancer heeding to WHO’s 2030 target: “I can proudly state that India is one of the few developing countries that have formulated the national cancer control program. As a leader in Asia, in 2016, we have launched the operational guidelines for screening of common cancers - cervical, breast, oral and Cervical Cancer. India along with 194 others countries has collectively resolved to work together for elimination of this major killer a goal which is achievable through 90% HPV vaccination coverage, 70% screening coverage and 90% treatment for cervical precancer and cancer including access to palliative care.”
The Union Health Minister explained how Government of India is offering intervention to end Cancer through the two wings of the Ayushman Bharat Programme: “We all know that effective primary HPV vaccination and secondary prevention approaches can prevent most cervical cancer cases. Today, India is strengthening all levels of cancercare. Treatment of cancer and precancerous lesions is being made accessible to the economically vulnerable population through our Pradhan Mantri Jan Arogya Yojna. Our primary health centres have now been transformed into wellness centers where screening is being undertaken on a massive scale. Each year, we are training doctors and paramedical staff for further improvement of their skills and provision of quality care to underprivileged women of rural areas. In the last 7 years, 29 new A.I.I.M.S and 25 more Regional Cancer Centers have been developed with state-of-the-art facilities. All of our 542 medical colleges and 64 post Graduate institutes are providing comprehensive care for pre-cancer and cancer patients. To add quality to the care, India has introduced a super specialty course in Gynaeoncology.”
He concluded his speech on a note of elation that the scientific deliberations of this conference will help in formulating strategies for Asia and other developing countries outside the continent. He wished for the success of IFCPC 2021 World Congress.